Literature DB >> 31789920

PPARγ and RhoBTB1 in hypertension.

Shi Fang1, Curt D Sigmund.   

Abstract

PURPOSE OF REVIEW: This review provides an up-to-date understanding of how peroxisome proliferator activated receptor γ (PPARγ) exerts its cardioprotective effect in the vasculature through its activation of novel PPARγ target genes in endothelium and vascular smooth muscle. RECENT
FINDINGS: In vascular endothelial cells, PPARγ plays a protective role by increasing nitric oxide bioavailability and preventing oxidative stress. RBP7 is a PPARγ target gene enriched in vascular endothelial cells, which is likely to form a positive feedback loop with PPARγ. In vascular smooth muscle cells, PPARγ antagonizes the renin-angiotensin system, maintains vascular integrity, suppresses vasoconstriction, and promotes vasodilation through distinct pathways. Rho-related BTB domain containing protein 1 (RhoBTB1) is a novel PPARγ gene target in vascular smooth muscle cells that mediates the protective effect of PPARγ by serving as a substrate adaptor between the Cullin-3 RING ubiquitin ligase and phosphodiesterase 5, thus restraining its activity through ubiquitination and proteasomal degradation.
SUMMARY: In the vasculature, PPARγ exerts its cardioprotective effect through its transcriptional activity in endothelium and vascular smooth muscle. From the understanding of PPARγ's transcription targets in those pathways, novel hypertension therapy target(s) will emerge.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31789920      PMCID: PMC7087486          DOI: 10.1097/MNH.0000000000000579

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   3.416


  78 in total

1.  Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells.

Authors:  K Takeda; T Ichiki; T Tokunou; Y Funakoshi; N Iino; K Hirano; H Kanaide; A Takeshita
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

Review 2.  The BACK domain in BTB-kelch proteins.

Authors:  Peter J Stogios; Gilbert G Privé
Journal:  Trends Biochem Sci       Date:  2004-12       Impact factor: 13.807

3.  Peroxisome proliferator-activated receptor gamma regulates angiotensin II-stimulated phosphatidylinositol 3-kinase and mitogen-activated protein kinase in blood vessels in vivo.

Authors:  Karim Benkirane; Emilie C Viel; Farhad Amiri; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2005-12-12       Impact factor: 10.190

4.  Hypertension-causing Mutations in Cullin3 Protein Impair RhoA Protein Ubiquitination and Augment the Association with Substrate Adaptors.

Authors:  Stella-Rita C Ibeawuchi; Larry N Agbor; Frederick W Quelle; Curt D Sigmund
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

5.  Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet.

Authors:  Andreas M Beyer; Willem J de Lange; Carmen M Halabi; Mary L Modrick; Henry L Keen; Frank M Faraci; Curt D Sigmund
Journal:  Circ Res       Date:  2008-07-31       Impact factor: 17.367

6.  Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-γ Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension.

Authors:  Pimonrat Ketsawatsomkron; Henry L Keen; Deborah R Davis; Ko-Ting Lu; Madeliene Stump; T Michael De Silva; Aline M Hilzendeger; Justin L Grobe; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2015-11-23       Impact factor: 10.190

7.  PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice.

Authors:  Michael J Ryan; Sean P Didion; Satya Mathur; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2004-01-26       Impact factor: 10.190

8.  Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension.

Authors:  Marc Iglarz; Rhian M Touyz; Farhad Amiri; Marie-France Lavoie; Quy N Diep; Ernesto L Schiffrin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-01       Impact factor: 8.311

9.  Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling.

Authors:  Vasyl Holobotovskyy; Mitali Manzur; Marianne Tare; Jennifer Burchell; Erin Bolitho; Helena Viola; Livia C Hool; Leonard F Arnolda; Douglas J McKitrick; Ruth Ganss
Journal:  Circ Res       Date:  2013-01-09       Impact factor: 17.367

10.  Hsp90-dependent assembly of the DBC2/RhoBTB2-Cullin3 E3-ligase complex.

Authors:  Jacob R Manjarrez; Liang Sun; Thomas Prince; Robert L Matts
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

View more
  5 in total

Review 1.  Kelch-like protein 3 in human disease and therapy.

Authors:  Yan Lin; Qian Li; Xiaofeng Jin
Journal:  Mol Biol Rep       Date:  2022-05-18       Impact factor: 2.742

Review 2.  Anti-inflammatory mechanisms of the vascular smooth muscle PPARγ.

Authors:  Masashi Mukohda; Hiroshi Ozaki
Journal:  J Smooth Muscle Res       Date:  2021

3.  Explore the Role of the rs1801133-PPARG Pathway in the H-type Hypertension.

Authors:  Xiuwen Liang; Tingting He; Lihong Gao; Libo Wei; Di Rong; Yu Zhang; Yu Liu
Journal:  PPAR Res       Date:  2022-03-20       Impact factor: 4.964

4.  Astragalus membranaceus and Salvia miltiorrhiza Ameliorate Hypertensive Renal Damage through lncRNA-mRNA Coexpression Network.

Authors:  Le Zhou; Cong Han; Yao Liu; Tao Cui; Zhen Shen; Xiang-Yu Li; Yue-Hua Jiang; Wei Li
Journal:  Biomed Res Int       Date:  2022-09-09       Impact factor: 3.246

5.  Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer.

Authors:  Chung-Chieh Chiao; Yen-Hsi Liu; Nam Nhut Phan; Nu Thuy An Ton; Hoang Dang Khoa Ta; Gangga Anuraga; Do Thi Minh Xuan; Fenny Fitriani; Elvira Mustikawati Putri Hermanto; Muhammad Athoillah; Vivin Andriani; Purity Sabila Ajiningrum; Yung-Fu Wu; Kuen-Haur Lee; Jian-Ying Chuang; Chih-Yang Wang; Tzu-Jen Kao
Journal:  Diagnostics (Basel)       Date:  2021-11-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.